probenecid has been researched along with cefazolin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Tune, BM | 1 |
| Bor, A; Soback, S; Ziv, G | 1 |
| Ashcraft, SM; Donecker, JM; Sams, RA | 1 |
| Brown, G; Clarke, AM; Zemcov, SJ | 1 |
| Athan, E; Chambers, F; Gibson, K; Grayson, ML; McDonald, M; Munckhof, WJ; Paull, P | 1 |
| Anzai, N; Babu, E; Endou, H; Enomoto, A; Huang, XL; Khamdang, S; Narikawa, S; Noshiro, R; Onozato, ML; Piyachaturawat, P; Takeda, M; Tojo, A | 1 |
| Dillon, EC; Spina, SP | 1 |
| Cox, VC; Zed, PJ | 1 |
| Edwards, J; Green, P; Haase, D | 1 |
| Khangura, S; Kissoon, N; Kodeeswaran, T; Wallace, J | 1 |
| Mitsuoka, K; Nakakariya, M; Nakanishi, T; Shima, Y; Shirasaka, Y; Tamai, I | 1 |
| Bader, MS; Hawboldt, J; Twells, L | 1 |
| Campbell, SG; Dalen, D; Eppler, J; Fry, A; Zed, PJ | 1 |
| Begg, EJ; Chin, PKL; Everts, R; Moore, GA; Zhang, M | 1 |
| Aliter, H; El Khateeb, O; Nasser, AS; Stewart, K | 1 |
2 review(s) available for probenecid and cefazolin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Once-daily cefazolin and probenecid for skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Biological Availability; Cefazolin; Half-Life; Humans; Male; Probenecid; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Uricosuric Agents | 2004 |
3 trial(s) available for probenecid and cefazolin
| Article | Year |
|---|---|
Effect of probenecid on cefazolin serum concentrations.
Topics: Adult; Cefazolin; Drug Interactions; Humans; Male; Probenecid | 1993 |
Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefazolin; Ceftriaxone; Cellulitis; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Probenecid; Uricosuric Agents | 2002 |
Effect of chronic probenecid therapy on cefazolin serum concentrations.
Topics: Administration, Oral; Adult; Aged; Cefazolin; Drug Interactions; Female; Humans; Injections, Intravenous; Male; Middle Aged; Probenecid | 2003 |
18 other study(ies) available for probenecid and cefazolin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Gonorrhea. Recommended treatment schedules--1974.
Topics: Adolescent; Adult; Age Factors; Ampicillin; Anti-Bacterial Agents; Cefazolin; Child; Child, Preschool; Endophthalmitis; Erythromycin; Female; Follow-Up Studies; Gonorrhea; Hospitalization; Humans; Infant; Infant, Newborn; Male; Penicillin G; Penicillin G Procaine; Pharyngeal Diseases; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Salpingitis; Sex Factors; Spectinomycin; Tetracycline | 1975 |
Relationship between the transport and toxicity of cephalosporins in the kidney.
Topics: Acute Kidney Injury; Aminohippuric Acids; Animals; Animals, Newborn; Biological Transport; Cefazolin; Cephaloridine; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Guinea Pigs; Kidney Cortex; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Male; Probenecid; Rabbits; Rats | 1975 |
Clinical pharmacology of cefazolin in calves.
Topics: Animals; Cattle; Cefazolin; Drug Interactions; Gram-Negative Bacteria; Kinetics; Male; Probenecid | 1987 |
Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares.
Topics: Administration, Oral; Animals; Biological Availability; Cefazolin; Female; Horses; Injections, Intravenous; Kinetics; Probenecid | 1986 |
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Cefadroxil; Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cell Line; Cell Survival; Cephaloridine; Cephalosporins; Cephalothin; Dinoprost; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Mice, Transgenic; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Transfection; Uricosuric Agents | 2003 |
A blistering disease: bullous erysipelas.
Topics: Anti-Bacterial Agents; Blister; Cefazolin; Cellulitis; Diabetes Mellitus, Type 2; Erysipelas; Humans; Male; Middle Aged; Probenecid; Uricosuric Agents | 2006 |
Management of cellulitis in a pediatric emergency department.
Topics: Academic Medical Centers; Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Anti-Bacterial Agents; British Columbia; Case-Control Studies; Cefazolin; Cellulitis; Cephalexin; Child; Child, Preschool; Cloxacillin; Emergency Service, Hospital; Female; Humans; Infant; Infusions, Intravenous; Male; Patient Admission; Probenecid; Retrospective Studies; Staphylococcus aureus; Streptococcus pyogenes | 2007 |
Organic anion transporter OAT1 is involved in renal handling of citrulline.
Topics: Animals; Biological Transport; Catecholamine Plasma Membrane Transport Proteins; Cefazolin; Cell Line; Citrulline; Glutarates; Humans; Kidney; Male; Models, Animal; Octamer Transcription Factor-1; Octamer Transcription Factor-2; Organic Anion Transport Protein 1; p-Aminohippuric Acid; Probenecid; Rats; Rats, Wistar | 2009 |
Risk factors of cellulitis treatment failure with once-daily intravenous cefazolin plus oral probenecid.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefazolin; Cellulitis; Chi-Square Distribution; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Logistic Models; Male; Middle Aged; Peripheral Vascular Diseases; Probenecid; Retrospective Studies; Risk Factors; Treatment Failure; Veins | 2011 |
Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial.
Topics: Adjuvants, Pharmaceutic; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Canada; Cefazolin; Cephalexin; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Probenecid; Prospective Studies; Soft Tissue Infections | 2018 |
Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography-Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactams; Cefazolin; Cephalexin; Child; Chromatography, High Pressure Liquid; Drug Monitoring; Floxacillin; Humans; Limit of Detection; Middle Aged; Plasma; Probenecid; Tandem Mass Spectrometry; Young Adult | 2018 |
Successful drainage of periaortic graft abscess and transcatheter aortic valve replacement in the same setting-A hybrid approach.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Aortic Valve; Aortic Valve Stenosis; Cefadroxil; Cefazolin; Drainage; Heart Valve Prosthesis; Humans; Male; Methicillin; Probenecid; Rifampin; Transcatheter Aortic Valve Replacement | 2022 |